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A B S T R A C T
Helicteres angustifolia L. (H. angustifolia) has been widely used as a remedy against various types of illness relating
to immune response, such as inﬂammations and fever. In order to characterize the structure and identify the
immunomodulatory activity of polysaccharide from H. angustifolia, a polysaccharide fraction (SPF3-1) was
puriﬁed from H. angustifolia by using DEAE Sepharose Fast Flow and Sephacry S-400 chromatography, suc-
cessively. Physicochemical analysis demonstrated that SPF3-1 is an acidic heteropolysaccharide with a mole-
cular weight of about 13.36 kDa; in vitro immunomodulatory assay reﬂects that SPF3-1 could signiﬁcantly (p <
0.05) enhance the proliferation of macrophages, stimulate the macrophages phagocytic capacity, as well as
induce NO and immunomodulatory cytokines generation. All the results suggest that SPF3-1 from H. angustifolia
possesses potent immunomodulatory activity and could be further developed as new products for medicines or
functional foods.
1. Introduction
Immunity is deﬁned as the ability of host defence against various
infectious diseases. Until now, a number of chemically synthesized
compounds have been used as immunomodulators to regulate the
functioning of the immune system. However, some adverse eﬀects, such
as hepatotoxicity, nephrotoxicity and hypersensitivity limit their clin-
ical usefulness [1]. In recent years, polysaccharides from natural
sources have been paid much attention owing to their nontoxic prop-
erties and strong immunomodulatory activities [2,3]. Thus, it is de-
manding for isolation and identiﬁcation of novel immunomodulatory
polysaccharides from natural sources with additional safety and eﬀec-
tiveness.
Helicteres angustifolia L. (H. angustifolia) is a traditional medicinal
herb widely distributed in southern China, Laos, and other Asian
countries. So far, this plant has been used as a folk medicine for the
treatment of various diseases such as ﬂu [4], fever, cold, inﬂammation,
and diabetes [5]. Previous phytochemical research of this plant focused
on isolation, analysis or determination of quinones, triterpenoids [6,7],
lignans, and alkaloids [8]. Biological studies of this plant have de-
monstrated its antioxidant, antitumor [9], and anti-diabetic activities
[10]. In addition, our recent study has indicated that crude poly-
saccharide (HACP) extracted from H. angustifolia inhibited tumor pro-
gression and metastasis in 4T1 tumor-bearing mice [11]. However, the
structure features and the activation abilities on macrophages of its
major fractions are not clear yet.
In this study, the major bioactive fraction of HACP was puriﬁed
stepwise with DEAE Sepharose Fast Flow and Sephacry S-400 column
chromatography, successfully. The primary structure features and mo-
lecular weight of the obtained polysaccharide fraction were de-
termined. Moreover, its in vitro immunomodulatory activities on mac-
rophages were also evaluated.
2. Materials and methods
2.1. Plant material and reagents
Fresh H. angustifolia roots were collected from Laos in June 2015.
The roots were then cleaned and dried at 40 °C, and ground into ﬁne
powder for further use.
Dulbecco’s modiﬁed eagle medium (DMEM), streptomycin, peni-
cillin and fetal bovine serum (FBS) were obtained from GIBCO (Grand
Island, NY, USA). Griess reagent, lipopolysaccharide (LPS), {3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide} (MTT) were
purchased from Sigma Aldrich, Inc. (Saint Louis, MO, USA). DEAE
Sepharose Fast Flow and Sephacry S-400 were obtained from GE
Healthcare Bio-sciences (Uppsala, Sweden). Mouse TNF-α, IL-2, IL-4,
IL-6, and IL-10 ELISA Kits were purchased from eBioscience (San Diego,
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T
CA, USA). Carbazole and D-Galacturonic acid were purchased from
Wako (Japan). Protein Quantiﬁcation Kit-Rapid was obtained from
Dojindo Molecular Technologies (Japan). All the reagents used in this
study were of analytical grade.
2.2. Extraction and separation of HACP
The crude polysaccharide (HACP) was extracted from H. angustifolia
according to the method as described previously [11]. The HACP was
then puriﬁed sequentially by using DEAE Sepharose Fast Flow anion-
exchange chromatography and Sephacryl S-400 size exclusion chro-
matography. Brieﬂy, approximately 300mg of HACP was dissolved in
10mL of ultrapure water and applied to DEAE Sepharose Fast Flow
column (450×40mm), followed by eluting stepwise with ultrapure
water, 0.1, 0.3, and 0.5M NaCl at a ﬂow rate of 3mL/min. The elution
(6mL/tube) of each fraction was collected and detected using the
phenol-sulfuric acid method [12]. Totally 600mL of wash solution was
used for each fraction. Then, the fractions were concentrated at 50°C by
rotary evaporation under reduced pressure, and lyophilized to obtain
SPF1, SPF2, SPF3 and SPF4, respectively. Fraction SPF3 was further
fractionated with Sephacry S-400 column (450×20mm) eluted with
ultrapure water at a ﬂow rate of 0.5mL/min. The fractions (3 mL/tube)
were collected and analysed by the method mentioned above. Finally,
the major fraction named SPF3-1 was then collected, and lyophilized to
light yellow powder.
2.3. Cell line and culture
Mouse macrophage cell RAW264.7 and human ﬁbrosarcoma
HT1080 cell were obtained from Riken Cell Bank (Tsukuba, Japan).
Cells were cultured in DMEM media supplemented with 10% FBS, pe-
nicillin (100 U/mL) and streptomycin (100 μg/mL) at 37°C in an in-
cubator with 5% CO2 atmosphere.
2.4. Preliminary characterization of SPF3-1
2.4.1. Chemical composition and molecular weight (Mw)
The uronic acid content of SPF3-1 was determined by the modiﬁed
carbazole method according to a previous research [13]. Protein con-
tent was determined with the protein quantiﬁcation kit according to the
manufacture procedure.
The neutral monosaccharaides composition of SPF3-1 was de-
termined by using high performance anion exchange chromatography
(HPAEC) with pulsed amperometric detection (PAD). SPF3-1 (10mg)
was hydrolysed in a sealed tube with 4M of triﬂuoroacetic acid (TFA,
4mL) at 120°C for 4 h. After cooling to ambient temperature, the excess
TFA was removed, then the residue was re-dissolved in 10mL of ul-
trapure water, and the resultant solution was diluted for 50 times and
ﬁltered through a 0.22 μm ﬁlter. The derivatives were then performed
on a Dionex HPAEC-PAD system (Dionex, USA) with an advanced
gradient pump and eluent degas module. The monosaccharide compo-
sition was identiﬁed as described previously [14]. The Mw of SPF3-1
was determined by using a high-performance size elusion chromato-
graphy instrument equipped with a multi-angle laser light scattering
and refractive index (HPSEC-MALLS-RID) system according to the
method described by Yang et al. [15] with some modiﬁcations. The
HPSEC-MALLS-RID system consists of a pump (e2695, Waters, USA), a
HPSEC columns (TSKgel SuperMultipore PW-M, TOSOH, Japan), a
MALLS detector (DAWN HELEOSII, Wyatt Technology, Santa Barbara,
CA, USA), and a RI detector (OPtilab T-rex, Wyatt Technology, Santa
Barbara, CA, USA). SPF3-1 (10mg) was dissolved in 1mL of distilled
water and ﬁltered through a 0.22 μm ﬁlter. Twenty μL of SPF3-1 solu-
tion was injected into the HPSEC column and eluted with distilled water
at a ﬂow rate of 0.5mL/min.
2.4.2. FTIR and UV spectroscopy
The structure feature of SPF3-1 was analysed by using a Fourier
transform infrared spectrophotometer (FT/IR-300, JASCO, Japan).
SPF3-1 was ground with potassium bromide (KBr) powder and pressed
into a pellet for FTIR measurement at a frequency range of 4000 -
500 cm−1.
For UV spectrum analysis, the aqueous solution of SPF3-1 at 1.0mg/
mL was scanned at the wavelength from 190 to 600 nm on a UV–vis
spectrophotometer (UV-3100PC, SHIMADZU, Japan).
Fig. 1. Separation and puriﬁcation of HACP: (a) Elution proﬁles of HACP on the
chromatography column DEAE Sepharose Fast Flow; (b) Elution curve of
fraction SPF3 on size-exclusion chromatography Sephacry S-400.
Table 1
Chemical composition and molecular weight of SPF3-1.
Carbohydrate Mw Uronic acid Protein Phenol Neutral sugar composition (mol%)
(wt%) (kD) (wt%) (wt%) (wt%) Rha Glc Gal Ara Man Fuc Xyl
74.8 13.36 58.77 ± 1.64 1.09 ± 0.23 1.01 ± 0.58 22.1 4.5 18.2 37.3 2.0 1.1 14.8
Rha- rhamnose, Glc- glucose, Gal- galactose, Ara- arabinose, Man- mannose, Fuc-fucose, Xyl-xylose.
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2.4.3. Nuclear magnetic resonance (NMR) analysis
SPF3-1 (30mg) was dissolved in 0.6mL D2O in an NMR tube. 13C
NMR and 1H NMR analysis were performed on a Bruker AVANCE-600
NMR Spectrometer.
2.5. In vitro immunomodulatory activity of SPF3-1
2.5.1. Macrophage cell proliferation assay
The proliferation eﬀects of SPF3-1 on RAW 264.7 cell were identi-
ﬁed by using MTT assay as described previously [11]. Cells (5000 cell/
well) were treated with various concentrations of SPF3-1 (6.25–100 μg/
Fig. 2. Structure properties of SPF3-1: (a) UV spectrum of fraction SPF3; (b) FTIR spectrum of SPF3-1; (c) 13C NMR spectrum of SPF3-1; and (d) 1H NMR spectrum of
SPF3-1.
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mL) for 24 h. The OD values were determined at 490 nm using a Model
550 microplate reader (BIO-RED, Tokyo, Japan). And the macrophage
cell viability was then calculated using the following equation: Mac-
rophage cell viability (%)= 100 × (ODSPF3-1/ODControl), where OD
SPF3-1 means the optical density of the SPF3-1 treated groups, ODControl
is the optical density of control group.
2.5.2. Phagocytic activity determination
The phagocytic uptake ability of macrophages was measured ac-
cording to the method described previously [16] with some modiﬁca-
tions. Macrophages were pre-incubated in 96-well plates for 12 h and
then treated without/with SPF3-1 at various doses (6.25–100 μg/ml)
for 24 h, followed by addition of 100 μL of neutral red (0.7%, w/v) and
Fig. 2. (continued)
Table 2
Chemical shifts for the resonances in the 1H and 13C NMR spectra of SPF3-1.
Glycosyl residues Chemical shifts, δ (ppm)
C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6
→5)-α-Araf-(1→ 107.2/5.04 81.3/4.12 76.9/4.01 82.7/4.22 68.3/3.74/3.88 n.d.
→2,4)-α-Rhap-(1→ 99.8/4.97 76.3/4.12 71.8/3.87 73.1/3.47 70.6/3.69 16.9/1.15
→1)-α-GalpA-(4→ nd/4.97 68.9/3.85 69.9/3.86 78.1/4.31 72.4/4.73 n.d.
α-Araf-(1→ 107.8/5.15 84.4/4.22 79.4/4.03 n.d./4.11 62.8/3.81/3.73 n.d.
α-Rhap-(1→ 96.2/4.63 75.4/4.02 69.7/3.89 n.d. n.d. 17.1/1.31
n.d.: not detected.
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cultivation at 37°C for 1 h. Finally, the medium was discarded, and the
cells were washed with cold PBS for three times. Afterwards, cell lysis
buﬀer (1% glacial acetic acid: ethanol= 1:1, 100 μL/well) was added
and the cells were incubated at room temperature (25 ± 2°C) for an-
other 1 h, and then the optical density was measured at 540 nm by
using a microplate reader.
2.5.3. Measurement of nitric oxide (NO) and cytokines production
RAW 264.7 cells (1× 105 cells/well) were cultured in 48-well
plates and stimulated with or without various doses of SPF3-1
(6.25–100 μg/mL). After incubation for 24 h, the culture supernatant
was collected, and NO level was measured by using Griess reagent assay
[16]. And the cytokines TNF-α, IL-2, IL-4, IL-6 and IL-10 released in the
culture supernatant were determined by the ELISA Kits according to the
instruction of manufacturers. The cells treated with LPS (10 μg/mL)
were used as the positive control, and those cultured in DMEM medium
in the absence of SPF3-1 and LPS were used as the negative control.
2.5.4. Cytotoxic eﬀect of SPF3-1 on HT1080 cells
The cytotoxic eﬀect of SPF3-1 on human ﬁbrosarcoma HT1080 cell
was identiﬁed using MTT assay as described above. Cells were treated
with various concentrations of SPF3-1 (6.25–400 μg/mL) for 24 h, cells
without any treatment were used as control group.
2.5.5. Macrophage-mediated cytotoxicity
The macrophage-mediated cytotoxicity was identiﬁed according to
Mao et al. [17] and Wang et al. [18] with some modiﬁcations.
RAW264.7 cells were cultured in 24-well plate (2× 105 cells/well)
overnight for adherent, followed by LPS (10 μg/mL) or various con-
centrations of SPF3-1 treatment. The cells without any treatment was
used as the control group. After 24 h, the supernatant and adherent cells
were collected individually. Then, the supernatants were added to a 96-
well plate containing adherent HT1080 cells (target cell: 4× 103 cells/
well) and cultured for 48 h. HT1080 cell viability was identiﬁed by
using MTT assay. Simultaneously, 100 μL of the above SPF3-1 pre-ac-
tivated macrophage cells (eﬀector cells, 2× 105 cells/mL) were added
to a 96-well plate containing adherent HT1080 cells (target cells,
2× 103 cells/well) and co-incubated for 48 h. The HT1080 cells co-
incubated with macrophage cells which without SPF3-1 treatment was
used as negative control group. The cell viability was identiﬁed by
using MTT assay. And the HT1080 cell viability was calculated by using
the following equation: HT1080 cell activity (%)= 100 × (ODT - (ODS
- ODE)) / ODT, where ODT means the optical density of target cells
control, ODS is the optical density of tested sample, and ODE is the
Fig. 3. Eﬀects of SPF3-1 on the viability and phagocytosis of RAW264.7 mac-
rophage cells. (a) Eﬀects on macrophage cell viability; (b) Eﬀects of SPF3-1 on
macrophages phagocytosis activity. The cells were treated with various con-
centrations of SPF3-1 or LPS (10 μg/mL) for 24 h. Results are represented as
mean ± SD, n=5. *p<0.05, **p<0.01, and ***p<0.001 denote statistically
signiﬁcant diﬀerence between the treated and control groups.
Fig. 4. Eﬀect of SPF3-1 on NO, and cytokines production in macrophage cells.
(a) NO release in SPF3-1 treated macrophages; (b) Eﬀect of SPF3-1 on TNF-α
production; (c) Eﬀect of SPF3-1 on IL-2 generation；(d) Eﬀect of SPF3-1 on IL-4
generation; (e) Eﬀect of SPF3-1 on IL-6 generation; and (f) Eﬀect of SPF3-1 on
IL-10 generation. Results are represented as mean ± SD, n= 5. *p<0.05,
**p<0.01, and ***p<0.001 denote statistically signiﬁcant diﬀerence between
the treated and control groups.
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optical density of the eﬀector cells control.
2.6. Statistical analysis
All the data were expressed as means ± standard deviation (SD),
and the results used in this work were from at least three independent
experiments performed in triplicate. In addition, the statistics were
analysed using one-way analysis of variance (ANOVA) with the
Duncan’s multiple-range test. *p<0.05, **p<0.01, and ***p<0.001
were considered as statistically signiﬁcant.
3. Results and discussion
3.1. Puriﬁcation and characterization of HACP
3.1.1. Separation and puriﬁcation of HACP
Since HACP exhibited signiﬁcant immunomodulatory activity under
in vivo conditions [11], further separation and structure characteriza-
tion on its major fractions are necessary. In the present study, the HACP
was separated with DEAE Sepharose Fast Flow chromatography as
shown in Fig. 1a. Result indicates that the HACP was mainly composed
of three fractions (SPF1, SPF2, and SPF3) which were eluted with the
ultrapure water, 0.1M, and 0.3M NaCl, respectively. Due to the highest
macrophage cell proliferation eﬀect (data not shown), the fraction SPF3
was selected and its further separation was performed on a Sephacyl S-
400 column. Finally, the major fraction SPF3-1 (Fig. 1b) yielding 9.8%
of the amount of HACP was collected and lyophilized.
3.1.2. Monosaccharides composition and molecular weight
The chemical composition and molecular weight of SPF3-1 are
shown in Table 1. Results reveals that 58.77 ± 1.64% of SPF3-1 is
uronic acids. And its main neutral sugars are rhamnose (Rha), arabinose
(Ara) and galactose (Gal), indicating that the structure of SPF3-1 pos-
sibly consists of a rhamnogalacturonan backbone with arabinan and/or
arabinogalactan-rich side chain [19]. Small amounts of xylose (Xyl),
glucose (Glc), fucose (Fuc), and mannose (Man) are also detectable. The
protein content (1.09 ± 0.23%) is low in SPF3-1, evidenced by a lack
of absorbance at 260–280 nm in the UV spectrum (Fig. 2a) as well. In
addition, the molecular weight (Mw) of SPF3-1 was determined to be
13.36 kDa.
3.1.3. FTIR and NMR spectroscopy
The FTIR spectrum of SPF3-1 (Fig. 2b) reﬂects that SPF3-1 has the
typical characteristic absorption bands of polysaccharide at 4000–500
cm−1. The strong absorption at 3433 cm-1 and weak peak at 2938 cm-1
are the stretching absorption of OeH and CeH stretching vibrations,
respectively [20,21]. The absorptions occurring at around 1737 and
1639 cm−1 can be assigned to ester carbonyl (C]O) groups and car-
boxylate ion stretching band (COO−), respectively, reﬂecting the ex-
istence of uronic acids in SPF3-1 [22,23]. This result to a great extent is
consistent with the uronic content identiﬁed in Table 1. The peak at
1248 cm-1 is characteristic absorptions of C]O dilatation vibration
[19]. Besides, the peaks at 1035 and 1079 cm−1 are attributed to the
arabinofuranose units and galactopyanose from the backbone of ara-
binogalactan. Moreover, the absorption peak at 625 cm−1 signals that
Fig. 4. (continued) Fig. 4. (continued)
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SPF3-1 contains α-conﬁgurations [24].
The structure feature of SPF3-1 was further analysed by the NMR
spectra (Fig. 2c and 2d) and the signals of SPF3-1 in 1H NMR and 13C
NMR spectra were identiﬁed according to previous literatures [25–29].
The region ranging from 3.0 to 5.5 ppm (1H NMR) and 60–110 ppm
(13C NMR) are typical of polysaccharides. As summarized in Table 2,
the anomeric carbon signals at δ 107.8, 107.2, 99.8, and 96.2 ppm and
those of anomeric protons at δ 5.15, 5.04, 4.97, and 4.63 ppm of SPF3-1
correspond with C-1 and H-1 of anomeric residues α-Araf-(1→,→5)-α-
Araf-(1→, →2,4)-α-Rhap-(1→, and α-Rhap-(1→ residues, respectively.
In addition, the signals at δ 68.9, 69.9, 78.1 and 72.4 ppm are assigned
to C-2, C-3, C-4, and C-5 of 1→)-α-GalpA-(4→). The 1H signals at δ
5.14/4.98 ppm and 13C signal at 53.28 ppm of SPF3-1 prove that the α-
GalpA is partially methyl esteriﬁed. The signal at δ 17.1/1.31 ppm is
assigned to the C-6/H-6 of α-L-Rhap.
3.2. In vitro immunomodulatory activity
3.2.1. Eﬀects of SPF3-1 on the viability and phagocytosis of RAW264.7
cells
Macrophage cell, one of the most important immune cells of innate
immune system, always act as the ﬁrst eﬀector cell to aging cells, pa-
thogens and cancer cells [30]. The activation of macrophages has been
considered as a primary and necessary step for immune system stimu-
lation. Therefore, in the present study, macrophage cells were used as
an in vitro cell model to investigate the immunomodulatory eﬀect of
SPF3-1. According to Fig. 3a, SPF3-1 exhibits an obvious proliferation
eﬀect on macrophage cells, achieving a cell viability of 159.6 ± 6.9%
at 6.25 μg/mL. Besides, the proliferation eﬀect increased with the in-
crease in SPF3-1 concentration, reaching its maximum cell viability of
199 ± 10.7% at 100 μg/mL.
Phagocytosis is one of the primary features for macrophages re-
sponse to pathogens and cancer cells [21]. Analysis of the phagocytosis
capacity of activated macrophages can reﬂect the eﬀects of tested
sample on immune function. In the present study, SPF3-1 was found to
signiﬁcantly enhance the phagocytosis of macrophages in a dose-de-
pendent manner when its concentrations varied from 12.5 to 100 μg/
mL (Fig. 3b). At the highest treatment concentration of 100 μg/mL, the
phagocytosis ability increased to 1.9 times of the control group, re-
ﬂecting that administration of SPF3-1 could eﬃciently induce macro-
phages cell immune response.
3.2.2. Increase eﬀects of SPF3-1on NO and cytokines generation in
macrophages
As a kind of important molecules produced by macrophages, NO
plays a vital role in the regulation of apoptosis and host defence against
pathogens and tumor cells [31,32]. At the same time, NO could also
enhance the lysis and phagocytosis of macrophages [33]. Thus, the
ability to release NO by macrophages reﬂects the eﬀects of poly-
saccharides on immune function. In this work, a signiﬁcant increase in
NO release was detected in various SPF3-1 treated macrophages,
showing a dose-dependent manner (Fig. 4a). Particularly, the NO pro-
duction was 10.40 ± 0.56 μM at 100 μg/mL of SPF3-1 treated group,
signiﬁcantly higher than the control group (3.91 ± 0.32 μM).
Cytokines are small molecular proteins secreted by activated mac-
rophages. They can mediate and regulate immune response [18].
Among them, TNF-α has been recognized as an important host reg-
ulatory molecule with tumor necrosis activity. In the present study, the
TNF-α release in the untreated control group was low
(97.46 ± 5.40 pg/mL), while the treatment with SPF3-1 resulted in a
signiﬁcant increase in TNF-α production compared with the control
group (Fig. 4b). The highest level of 336.82 ± 4.63 pg/mL was ob-
tained in the 100 μg/mL SPF3-1 treated group, exhibiting not so much
diﬀerence with the positive LPS control (356.33 ± 12.64 pg/mL). As
important regulators of host defense responses, IL-2, IL-4, and IL-6
contribute to the diﬀerentiation, maturation and activation of cells
[34]. As shown in Fig. 4c–e, SPF3-1 exhibited a positive eﬀect on IL-2,
IL-4, and IL-6 production in the culture medium of macrophages. In
comparison with the untreated cells, SPF3-1 at the concentration of
100 μg/mL caused a 0.38, 1.31, and 3.66-fold increase in the produc-
tion of IL-2, IL-4, and IL-6, respectively. In addition, with respect to
Fig. 5. SPF3-1 induced cytotoxicity of macrophages against HT1080 tumor
cells: (a) Cytotoxicity of SPF3-1 activated RAW264.7 towards HT1080 tumor
cells; (b) Cytotoxic eﬀect of culture supernatant from SPF3-1 treated macro-
phages; and (c) Eﬀects of SPF3-1 on HT1080 cell viability. Results are re-
presented as mean ± SD, n= 5. *p < 0.05, **p < 0.01, and ***p < 0.001
denote statistically signiﬁcant diﬀerence between the treated and control
groups.
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anti-inﬂammatory substances, IL-10 has been recognized as a master
anti-inﬂammatory cytokine exhibiting immunosuppressive eﬀects ne-
cessary for inﬂammatory resolution [2]. As shown in Fig. 4f, among the
tested dosage, SPF3-1 resulted in an obvious increase of IL-10 produc-
tion. Taken together, we can conclude that the macrophages activation
ability of SPF3-1 is associated with the stimulatory action on the release
of NO, and cytokines TNF-α, IL-2, IL-4, IL-6 and IL-10.
3.2.3. Cytotoxic eﬀect of SPF3-1 treated RAW264.7 cells on HT1080 cells
As seen in Fig. 5a, the macrophages induced by SPF3-1 signiﬁcantly
reduced the cell proliferation of HT1080 cells when compared with the
control group (p < 0.01). The maximum inhibition eﬀect
(41.5±2.8%) was determined at 100 μg/mL of SPF3-1 treated group,
greatly in agreement with the above observation on the resultant en-
hanced macrophages immune response and phagocytosis capacity
against cancer cells after pretreatment with SPF3-1. Meanwhile, co-
incubation with culture supernatant from SPF3-1 treated macrophages
resulted in a signiﬁcant reduction in cell viability of HT1080 cells
(Fig. 5b). The above results demonstrate that after pre-treatment with
SPF3-1, the macrophages and culture media possessed a cytotoxic ac-
tivity against HT1080 cells. No direct cytotoxic eﬀect of SPF3-1 on
HT1080 cell was detected in this work (Fig. 5c), indicating that SPF3-1
exhibits an indirect cytotoxicity on HT1080 cancer cells probably by
stimulating macrophages immune response.
The immunomodulatory activity of polysaccharides on macro-
phages is usually correlated with its structure, monosaccharide com-
position, and molecular weight [35]. Previous results suggest that
polysaccharides are mainly composed of Ara, Xyl, Gal, and high content
of uronic acid play a positive role in the stimulation of macrophages
[30,36,37]. In this study, with relative higher Ara, Gal, Xyl and uronic
acid, SPF3-1 was found to strongly stimulate macrophages immune
response. In addition, the molecular weight of SPF3-1 was about
13.36 kDa, signiﬁcantly in accordance with the conclusion that poly-
saccharides from natural plants with lower molecular weight was
proven to possess higher immunomodulatory activities [38].
4. Conclusions
In conclusion, results revealed that the polysaccharide fraction
SPF3-1 from HACP displays immunomodulatory activities on macro-
phages via increasing the cell proliferation, phagocytosis ability, and
stimulating NO and immunomodulatory cytokines release. This study
provides evidence that SPF3-1 from H. angustifolia have potent im-
munomodulatory properties and can be developed as potential im-
munomodulators for functional foods or drugs.
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